Search Results - Gallo L
- Showing 1 - 1 results of 1
-
1
Tildrakizumab for the Treatment of Moderate-to-Severe Psoriasis: Results from 52 Weeks Real-Life Retrospective Study by Ruggiero A, Fabbrocicni G, Cacciapuoti S, Potestio L, Gallo L, Megna M
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book